Drug Type Small molecule drug |
Synonyms KP-106 |
Target |
Action agonists |
Mechanism adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H27N5O |
InChIKeyDRLPEFJOKVYESM-JSGCOSHPSA-N |
CAS Registry1032291-80-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Attention Deficit Disorder With Hyperactivity | Phase 1 | United States | 22 Oct 2009 |





